Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT00823927Completed

Alveolar Macrophage Proteomics in HIV-associated Emphysema

Role: lead

NCT00814203Completed

A Registry of COPD Patients to be Used for Future Studies

Role: lead

NCT00701896Not ApplicableCompleted

Smoking Cessation Using Motivational Therapy and Varenicline

Role: lead

NCT01162642Not ApplicableCompleted

Green Tea Anticancer Mechanisms in Smokers

Role: lead

All 4 trials loaded